SEC 13F Intelligence

Integral Health Asset Management, LLC / RETAEUR

Integral Health Asset Management, LLC’s Reata Pharmaceuticals Inc Position

Does Integral Health Asset Management, LLC own Reata Pharmaceuticals Inc (RETAEUR)? Not currently — the last reported position was 120.0K shares worth $12M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$12M
Q2 2023
Shares
120.0K
% of Portfolio
+1.51%
Quarters Held
11
position exited

Position History RETAEUR

Reported value by quarter
Q3 ’20: $4MQ3 ’20Q4 ’20: $6MQ1 ’21: $4MQ1 ’21Q2 ’21: $6MQ3 ’21: $4MQ3 ’21Q4 ’21: $3MQ1 ’22: $1MQ1 ’22Q2 ’22: $3MQ4 ’22: $3MQ4 ’22Q1 ’23: $6MQ2 ’23: $12MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2023120.0K$12M+1.51%
Q1 202371.0K$6M+1.30%
Q4 202285.0K$3M+0.68%
Q2 2022104.4K$3M+0.65%
Q1 202235.0K$1M+0.30%
Q4 2021103.0K$3M+0.75%
Q3 202135.0K$4M+1.01%
Q2 202142.0K$6M+1.64%
Q1 202144.0K$4M+1.25%
Q4 202050.0K$6M+1.84%
Q3 202040.0K$4M+1.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Integral Health Asset Management, LLC’s full portfolio or all institutional holders of RETAEUR.